Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 141,866 | 441,714 | 83,961 | 79,139 | 15,975 |
| Receivables | 138,371 | 98,867 | 44,133 | 26,773 | 14,078 |
| Inventories | 37,080 | 23,719 | 11,793 | 5,767 | 2,504 |
| Other current assets | 0 | 0 | 4,839 | 4,466 | 1,033 |
| TOTAL | $330,280 | $571,189 | $153,189 | $117,850 | $34,464 |
| Non-Current Assets | |||||
| PPE Net | 115,611 | 33,778 | 20,775 | 12,815 | 4,588 |
| Investments And Advances | 3,678 | 3,789 | 8,353 | N/A | N/A |
| Intangibles | 592,823 | 258,764 | 74,714 | 40,127 | 40,399 |
| Other Non-Current Assets | 121,594 | 75,440 | 14,333 | 2,924 | 154 |
| TOTAL | $833,706 | $371,771 | $118,174 | $55,866 | $45,140 |
| Total Assets | $1,163,986 | $942,960 | $271,364 | $173,717 | $79,605 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,110 | 11,809 | 657 | N/A | 14 |
| Accounts payable and accrued liabilities | 88,809 | 42,718 | 22,372 | 11,433 | 8,615 |
| Accrued Expenses | 32,608 | 33,181 | N/A | N/A | N/A |
| Other current liabilities | 11,540 | 53,421 | 7,491 | 3,361 | 4,453 |
| TOTAL | $231,624 | $205,771 | $107,242 | $58,204 | $27,534 |
| Non-Current Liabilities | |||||
| Long Term Debt | 391,914 | 343,138 | 5,593 | 2,253 | N/A |
| Deferred Revenues | 402 | 6,994 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 23,832 | 27,780 | 51,845 | 54,414 | 49,124 |
| TOTAL | $516,986 | $383,859 | $62,668 | $61,084 | $50,507 |
| Total Liabilities | $748,610 | $589,629 | $169,910 | $119,288 | $78,040 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 338,777 | N/A | N/A | N/A | N/A |
| Common Shares | 0 | 0 | 304,043 | 252,372 | 123,844 |
| Retained earnings | -154,538 | -132,426 | -179,635 | -185,596 | -125,751 |
| Other shareholders' equity | 89,952 | 114,665 | -22,954 | -12,347 | 3,472 |
| TOTAL | $415,376 | $353,331 | $101,453 | $54,429 | $1,564 |
| Total Liabilities And Equity | $1,163,986 | $942,960 | $271,364 | $173,717 | $79,605 |